U.S. Markets close in 6 hrs 15 mins

New Research: Key Drivers of Growth for Ashland Global, Intellia Therapeutics, Thor Industries, Zogenix, BWX Technologies, and Heidrick & Struggles International — Factors of Influence, Major Initiatives and Sustained Production

NEW YORK, Dec. 17, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Ashland Global Holdings Inc. (ASH), Intellia Therapeutics, Inc. (NTLA), Thor Industries, Inc. (THO), Zogenix, Inc. (ZGNX), BWX Technologies, Inc. (BWXT), and Heidrick & Struggles International, Inc. (HSII), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

ASH DOWNLOAD: http://MarketSourceResearch.com/register/?so=ASH
NTLA DOWNLOAD: http://MarketSourceResearch.com/register/?so=NTLA
THO DOWNLOAD: http://MarketSourceResearch.com/register/?so=THO
ZGNX DOWNLOAD: http://MarketSourceResearch.com/register/?so=ZGNX
BWXT DOWNLOAD: http://MarketSourceResearch.com/register/?so=BWXT
HSII DOWNLOAD: http://MarketSourceResearch.com/register/?so=HSII

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Ashland Global Holdings Inc. (ASH), Intellia Therapeutics, Inc. (NTLA), Thor Industries, Inc. (THO), Zogenix, Inc. (ZGNX), BWX Technologies, Inc. (BWXT), and Heidrick & Struggles International, Inc. (HSII) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed December 13th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

ASHLAND GLOBAL HOLDINGS INC. (ASH) REPORT OVERVIEW

Ashland Global's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Ashland Global reported revenue of $956.00MM vs $880.00MM (up 8.64%) and analysts estimated basic earnings per share $0.15 vs -$0.92. For the twelve months ended September 30th, 2018 vs September 30th, 2017, Ashland Global reported revenue of $3,743.00MM vs $3,260.00MM (up 14.82%) and analysts estimated basic earnings per share $1.82 vs $0.01 (up 18,100.00%). Analysts expect earnings to be released on February 4th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.46. The estimated EPS forecast for the next fiscal year is $4.48 and is expected to report on November 5th, 2019.

To read the full Ashland Global Holdings Inc. (ASH) report, download it here: http://MarketSourceResearch.com/register/?so=ASH

-----------------------------------------

INTELLIA THERAPEUTICS, INC. (NTLA) REPORT OVERVIEW

Intellia Therapeutics' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Intellia Therapeutics reported revenue of $7.41MM vs $7.32MM (up 1.24%) and analysts estimated basic earnings per share -$0.53 vs -$0.44. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Intellia Therapeutics reported revenue of $26.12MM vs $16.48MM (up 58.49%) and analysts estimated basic earnings per share -$1.88 vs -$1.42. Analysts expect earnings to be released on March 13th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$0.61. The estimated EPS forecast for the next fiscal year is -$2.49 and is expected to report on March 13th, 2019.

To read the full Intellia Therapeutics, Inc. (NTLA) report, download it here: http://MarketSourceResearch.com/register/?so=NTLA

-----------------------------------------

THOR INDUSTRIES, INC. (THO) REPORT OVERVIEW

Thor Industries' Recent Financial Performance

For the three months ended October 31st, 2018 vs October 31st, 2017, Thor Industries reported revenue of $1,755.98MM vs $2,231.67MM (down 21.32%) and analysts estimated basic earnings per share $0.26 vs $2.44 (down 89.34%). For the twelve months ended July 31st, 2018 vs July 31st, 2017, Thor Industries reported revenue of $8,328.91MM vs $7,246.95MM (up 14.93%) and analysts estimated basic earnings per share $8.17 vs $7.12 (up 14.75%). Analysts expect earnings to be released on March 6th, 2019. The report will be for the fiscal period ending January 31st, 2019. Reported EPS for the same quarter last year was $1.92. The estimated EPS forecast for the next fiscal year is $6.48 and is expected to report on September 19th, 2019.

To read the full Thor Industries, Inc. (THO) report, download it here: http://MarketSourceResearch.com/register/?so=THO

-----------------------------------------

ZOGENIX, INCc. (ZGNX) REPORT OVERVIEW

Zogenix's Recent Financial Performance

For the twelve months ended December 31st, 2017 vs December 31st, 2016, Zogenix reported revenue of $9.82MM vs $28.85MM (down 65.96%) and analysts estimated basic earnings per share -$4.65 vs -$2.81. Analysts expect earnings to be released on March 5th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$1.14. The estimated EPS forecast for the next fiscal year is -$3.92 and is expected to report on March 5th, 2019.

To read the full Zogenix, Inc. (ZGNX) report, download it here: http://MarketSourceResearch.com/register/?so=ZGNX

-----------------------------------------

BWX TECHNOLOGIES, INC. (BWXT) REPORT OVERVIEW

BWX Technologies' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, BWX Technologies reported revenue of $425.51MM vs $419.36MM (up 1.47%) and analysts estimated basic earnings per share $0.78 vs $0.47 (up 65.96%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, BWX Technologies reported revenue of $1,687.74MM vs $1,550.57MM (up 8.85%) and analysts estimated basic earnings per share $1.49 vs $1.79 (down 16.76%). Analysts expect earnings to be released on February 26th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.47. The estimated EPS forecast for the next fiscal year is $2.52 and is expected to report on February 26th, 2019.

To read the full BWX Technologies, Inc. (BWXT) report, download it here: http://MarketSourceResearch.com/register/?so=BWXT

-----------------------------------------

HEIDRICK & STRUGGLES INTERNATIONAL, INC. (HSII) REPORT OVERVIEW

Heidrick & Struggles International's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Heidrick & Struggles International reported revenue of $192.34MM vs $164.47MM (up 16.95%) and analysts estimated basic earnings per share $0.87 vs $0.44 (up 97.73%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Heidrick & Struggles International reported revenue of $640.06MM vs $600.91MM (up 6.52%) and analysts estimated basic earnings per share -$2.60 vs $0.83. Analysts expect earnings to be released on February 25th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.15. The estimated EPS forecast for the next fiscal year is $2.44 and is expected to report on February 25th, 2019.

To read the full Heidrick & Struggles International, Inc. (HSII) report, download it here: http://MarketSourceResearch.com/register/?so=HSII

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that’s ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com

© 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.